Pharmacoinvasive Strategy
Pharmacoinvasive Strategy is a clinical management approach in acute coronary syndrome that combines initial pharmacological reperfusion with subsequent planned invasive coronary intervention to optimize myocardial perfusion and clinical outcomes.
40
Publications
1.3K
Citations
286
Authors
145
Institutions
Publications per year
2017–2026
14
40
Nicolas Danchin, Pierre Coste, Jean Ferrières et al. · Circulation · 2008 · 327 citations
Kevin R. Bainey, Paul W. Armstrong, Yinggan Zheng et al. · Circulation Cardiovascular Interventions · 2019 · 68 citations · Full text
1–5 of 40
286
7
h-index
6
h-index
6
h-index
5
h-index
5
h-index
1–5 of 286
145
Canadian VIGOUR Centre
Edmonton, Canada
9 h-index
27 publications
909 citations

University of Alberta
Edmonton, Canada
9 h-index
30 publications
1K citations

Universidade Federal de São Paulo
São Paulo, Brazil
5 h-index
40 publications
768 citations
Université de Lille
Lille, France
4 h-index
4 publications
120 citations

University of Nottingham
Nottingham, United Kingdom
3 h-index
3 publications
104 citations
NIHR Leicester Cardiovascular Biomedical Research Unit
Leicester, United Kingdom
3 h-index
3 publications
107 citations
Université Paris Cité
Paris, France
3 h-index
22 publications
6.6K citations

University of Belgrade
Belgrade, Serbia
2 h-index
2 publications
50 citations
1–8 of 145
2 publications · 27 citations
2
h-index
2 publications · 116 citations
2
h-index
2 publications · 33 citations
2
h-index
AHJ · 2 publications · 80 citations
2
h-index
2 publications · 61 citations
2
h-index
1–5